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A key step toward the discovery of a gene related to a trait is the finding of an association between the trait and
one or more haplotypes. Haplotype analyses can also provide critical information regarding the function of a gene;
however, when unrelated subjects are sampled, haplotypes are often ambiguous because of unknown linkage phase
of the measured sites along a chromosome. A popular method of accounting for this ambiguity in case-control
studies uses a likelihood that depends on haplotype frequencies, so that the haplotype frequencies can be compared
between the cases and controls; however, this traditional method is limited to a binary trait (case vs. control), and
it does not provide a method of testing the statistical significance of specific haplotypes. To address these limitations,
we developed new methods of testing the statistical association between haplotypes and a wide variety of traits,
including binary, ordinal, and quantitative traits. Our methods allow adjustment for nongenetic covariates, which
may be critical when analyzing genetically complex traits. Furthermore, our methods provide several different global
tests for association, as well as haplotype-specific tests, which give a meaningful advantage in attempts to understand
the roles of many different haplotypes. The statistics can be computed rapidly, making it feasible to evaluate the
associations between many haplotypes and a trait. To illustrate the use of our new methods, they are applied to
a study of the association of haplotypes (composed of genes from the human-leukocyte-antigen complex) with
humoral immune response to measles vaccination. Limited simulations are also presented to demonstrate the validity
of our methods, as well as to provide guidelines on how our methods could be used.
Introduction
The recent sequencing of the human genome (Interna-
tional Human Genome Sequencing Consortium 2001;
Venter et al. 2001) provides an immense amount of data
that has strong potential to change the way we under-
stand common human diseases and ultimately may im-
prove their diagnosis, prognosis, and treatment (Collins
1999). Nonetheless, the deciphering of complex genetic
mechanisms poses a significant challenge. It is antici-
pated that, by use of improved genetic-marker maps,
particularly those with single-nucleotide polymorphisms
(SNPs) (The International SNP Map Working Group
2001), association studies will improve our ability to
detect susceptibility alleles for common complex diseases
(Risch 2000; Cardon and Bell 2001; Schork et al. 2001).
Furthermore, it is likely that haplotypes, which are spe-
cific combinations of nucleotides on the same chromo-
some, will provide more information on the complex
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relationship between DNA variation and phenotypes
than any single SNP can provide (Stephens et al. 2001a).
Haplotype analyses tend to focus either on fine map-
ping, to localize a susceptibility gene via linkage dise-
quilibrium (LD) with adjacent genetic markers, or on
the influence that the entire haplotype has on the trait.
For simple diseases, numerous statistical methods have
been proposed for Mendelian LD fine mapping (Hast-
backa et al. 1992; Kaplan et al. 1995; Terwilliger 1995;
Devlin et al. 1996; Guo 1997; Xiong and Guo 1997;
Lazzeroni 1998; Rannala and Slatkin 1998), most of
which require observed disease and normal chromo-
somes (i.e., haplotypes composed of marker and disease-
locus alleles) and are based on patterns of pairwise LD
measures between the genetic markers and the disease
gene. However, it is difficult to speculate about how
well the current LD-mapping strategies will work for
complex diseases.
In contrast to fine mapping, classical genetics has
demonstrated that the phenotypic effect of several mu-
tations at different sites within a gene can depend on
whether the mutations occur on the same chromosome
(in cis position, as a haplotype) or on opposite homol-
ogous chromosomes (in trans position). There is strong
evidence that several mutations in cis position within a
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single gene can interact to create a “super allele” that
has a large effect on the observed phenotype. Some ex-
amples in humans include a gene that influences intes-
tinal lactase activity (Hollox et al. 2001); a gene re-
sponsible for human lipoprotein lipase (Clark et al.
1998); theHPC2/ELAC2 gene, which increases the risk
for prostate cancer (Tavtigian et al. 2001); and a gene
that influences actions of catecholamines, which influ-
ence bronchodilation and, hence, asthma (Drysdale
2000). The biologic explanation for these haplotype ef-
fects is that several mutations in a gene cause several
amino acid changes in the ultimate protein product, and
the joint effect of these amino acid changes can have a
much larger influence on the function of the protein
product than any single amino acid change. This em-
phasizes the importance of examining candidate genes
by SNP haplotyping.
For unrelated subjects, haplotypes can be directly ob-
served whenever there is no more than one heterozygous
site. If there are H heterozygous sites, then the number
of pairs of haplotypes that are consistent with the ob-
served marker phenotypes is . Although the obser-H12
vations on codominant genetic markers are often referred
to as “genotypes,” we shall refer to them as “marker
phenotypes,” reserving the term “genotype” for when
linkage phase is known. The traditional method to de-
termine haplotypes is either pedigree analysis or molec-
ular haplotyping (limited to short DNA sequences)
(Michalatos-Beloin et al. 1996). Both of these methods
require enormous work either to collect a sufficient num-
ber of pedigree members or to perform the necessary
laboratory work. Although new genetic technology (e.g.,
conversion technology [Yan et al. 2000]) may improve
molecular haplotyping, the current methods are not ad-
equate for large-scale epidemiological studies of human
traits. To account for ambiguous haplotypes among un-
related subjects, several algorithms—including a parsi-
mony algorithm (Clark 1990), a Bayesian population
genetic model that uses coalescent theory (Stephens et
al. 2001b; Zhang et al. 2001), and maximum likelihood
(Terwilliger and Ott 1994; Excoffier and Slatkin 1995;
Hawley and Kidd 1995; Long et al. 1995)—have been
proposed. An advantage of the likelihood approach is
that, in addition to the estimated haplotype frequencies,
the posterior probabilities of the pairs of haplotypes that
are consistent with the observed marker phenotypes can
be computed for each subject. Our methods depend on
the likelihood approach and use the posterior proba-
bilities to account for haplotype ambiguities.
For case-control studies with unrelated subjects,
haplotype frequencies are often compared between
diseased cases and unaffected controls by use of a
likelihood-ratio statistic. The expectation-maximi-
zation (EM) algorithm is used to maximize the log-
likelihood for the pool of all subjects, , andln (L )total
then, separately, that for cases, , and that forln (L )cases
controls, . The likelihood-ratio statistic isln (L )controls
then , whichLRp 2[ln (L ) ln (L ) ln (L )]cases controls total
has an approximate distribution. For sparse data,2x
empirical P values may be more reliable. However,
maximization of the ln(L) is computer intensive,
which can limit computation of empirical P values.
Furthermore, this method does not provide statistical
evaluations of individual haplotypes, nor does it read-
ily generalize to other types of traits, such as quan-
titative traits.
Our alternative approach is based on efficient score
statistics, which provide both global tests and haplo-
type-specific tests. By use of generalized linear models
(GLMs), we generalize our methods to a wide variety
of traits and discuss ways to compute empirical P values
and to score haplotypes and multilocus genotypes. Our
new methods are illustrated by application to a study
of the association of HLA haplotypes with measles vac-
cination response, and limited simulations are provided
to illustrate some of the statistical properties of our
methods.
Statistical Methods
GLMs
To clarify our approach, we first derive score statistics
for situations in which the underlying genotype is not
ambiguous (e.g., when a single codominant marker locus
is evaluated or when haplotypes can be directly mea-
sured). Furthermore, we take a general approach so that
measured environmental covariates can be included to
develop score statistics for the genetic markers, adjusted
for environmental factors. Let y denote a measured trait,
let denote a vector of measured environmental fac-Xe
tors, including the intercept as the first element, and let
denote a vector of numerical codes for the markerXg
genotype, g. We assume that the covariates influence the
mean of the trait and not the scale, so that their effects
can be summarized by a function of the linear predictor
, where a denotes the regression param-′ ′hp X a X be g
eters for the intercept and environmental factors and
where b represents the effect of the genotype on the trait.
We derive score statistics to test the null hypothesis of no
association of the trait with the genotype, .H :bp 0o
To present some background on GLMs, we concate-
nate the covariates and their regression terms into single
vectors, so that and . The like-Zp (X FX ) gp (aFb)e g
lihood of a subject’s trait y given the vector Z can be
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expressed as a GLM for exponential family data (Mc-
Cullagh and Nelder 1983) according to
( )yh b h
( ) ( )L yFZ p exp  c y,f ,[ ]( )a f
where a, b, and c are known functions (special cases
of which are discussed later), is the dispersion pa-f
rameter, and for an arbitrary function ;′hp h(Z g) h ()
for our exposition, we assume canonical link functions
such that . The mean trait value is given by′hp Z g
, so that the link function f is given1 ′˜E (y)p yp f (Z g)
by .′˜f(y)p Z g
Score Tests in Absence of Ambiguity: Single-Locus or
Measured Haplotypes
When the underlying genotype is not ambiguous, the
score statistic for the vector Z is
N N( ) ln Li ˜y  yi iU p p Z , g i
g a(f)ip1 ip1
where is the fitted value for the ith subject accordingy˜i
to its covariate vector , is the regression parameter,Z gi
and N is the number of subjects. After regressing the
trait only on the environmental covariates, to determine
, we set and use to determine , so that˜ˆ ˆa bp 0 a yi
. Then, the score statistic for the genetic markers,U p 0aˆ
adjusted for environmental covariates, is
N
˜y  yi iU p X , (1)b gia(f)ip1
which is a measure of the covariation of the residuals
(from the regression on environmental factors) with the
genotype code.
The variance of under the null hypothesis, whichUb
accounts for the adjustment for the environmental co-
variates, is determined by , where1V p V  V V Vb bb ba aa ab
are the appropriate submatrices of the matrix .V V(U )ij g
Based on GLMs, it can be shown that
N ′′b (h )i ′V(U )p Z Z .g i i[ ]a(f)ip1
Without environmental covariates, there is only an in-
tercept to correct for, so that the variance simplifies to
N′′ ′b (h) X Xg• g•′V p X X  .b gi gi( )[ ]a(f) Nip1
A global score statistic can then be computed as Sp
. It is worth noting that, for binary data and a′ 1U V Ub b b
single covariate representing the allele dosage (e.g.,Xg
, 1, 2), the score statistic times is theX p 0 (N 1)/Ng
same as Armitage’s test for trend in proportions, which
is a popular statistic used to compare genotype fre-
quencies between cases and controls (Sasieni 1997; Dev-
lin and Roeder 1999).
Score Tests for Ambiguous Haplotypes
When linkage phase is unknown, the marker pheno-
types, m, may be consistent with a set of underlying
multilocus genotypes,G.We shall consider the joint like-
lihood of the trait and markers, conditional on the en-
vironmental covariates, , which is the standardL(y,mFX )e
way to account for “missing data” by the EM algorithm.
In our case, the underlying unobserved genotypes are
considered the missing data. The likelihood for a given
subject is
L ∝ P(y,mFX )p P(yFX ,X )P(g) ,e e g
gG
where the sum is over the set G of genotypes consistent
with marker phenotypes, m. The score statistic for the
effects of haplotypes, adjusted for environmental covari-
ates, can be shown to be
N
˜(y  y )i i ( )U p E X , (2)b p gia(f)ip1
where denotes the expectation over the posteriorE ()p
distribution of genotypes under the null hypothesis,
given the observed marker data. That is, E (X)pp
, where the posterior probability of a geno- X Q(g)gG g
type for a subject is . To computeQ(g)p P(g)/ P(g)gG
the genotype probabilities, , we first estimate theP(g)
haplotype probabilities by application of the EM algo-
rithm (Excoffier and Slatkin 1995) to the pool of all
subjects, which is appropriate under the null hypothesis,
and then multiply the relevant haplotype probabilities
(i.e., assuming Hardy-Weinberg equilibrium). Note the
similarities of equations (1) and (2), where is replacedXg
by its posterior expectation when linkage phase is
ambiguous.
Similar to the case when genotypes are not ambiguous,
the variance matrix of the vector can be determinedUb
by , but the ambiguity of the un-1V p V  V V Vb bb ba aa ab
derlying genotypes must now be considered. The vari-
ance matrix can be determined by the matrix ofV(U )g
negative second partial derivatives of ln(L), evaluated
under the null hypothesis. In our situation, this is equiv-
alent to computation of the variance of the score vector
when the EM algorithm is used to account for missing
data. As shown by Louis (1982), V(U)p E (J)p
, where J is the negative of the second′ ′[E (UU ) UU ]p
derivative matrix for the complete data and where
is the expected complete data information over theE (J)p
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Table 1
GLM Functions for Different Distributions
Distribution y˜ a (f) ′′b (h) /a (f)
Normal h 2jmse
21/jmse
Binomial h he / (1 e ) 1 ˜ ˜y (1 y)
Poisson he 1 y˜
NOTE.— .′ ′hp X a X be g
posterior distribution (i.e., conditional on the set ). TheG
first term of V(U) is the variance if there were no “miss-
ing data” due to unknown linkage phase, and the second
term is the penalty for incomplete linkage phase. Ap-
plying this variance computation to our score vector
results in
N ′′b (h )i ′V p X X ,aa ei eia(f)ip1
N ′′b (h )i ′( )V p X E X ,ab ei p gia(f)ip1
N ′′ 2
˜b (h ) (y  y )i i i ′( )V p  E X Xbb p gi gi[ ]2a(f) a(f)ip1
2
˜(y  y )i i ′( ) ( ) E X E X .p gi p gi2a(f)
The term is the usual covariance matrix for completeVaa
data, and is of similar form but with replaced byV Xab gi
its posterior expectation. In contrast, the term isVbb
equivalent to the variance of the score vector proposed
by Louis (1982) for incomplete data, thereby accounting
for ambiguous haplotypes.
To implement the score statistics for different types of
traits, we need merely to assume a distribution for the
trait and to make the appropriate substitutions for the
expected value of the trait, ; the dispersion parameter,y˜
; and the ratio . These functions are defined′′a(f) b (h)/a(f)
in table 1 for a few common distributions. Without en-
vironmental covariates, is the same for all subjects andy˜
can be estimated as the sample mean for a quantitative
trait, as the sample fraction of diseased subjects for a
binary trait, or as the sample event rate for a trait with
a Poisson distribution. It is straightforward to extend
our methods to other types of traits and distributions
by defining the appropriate functions; for example, we
have extended our methods to analyze ordinal traits
(e.g., unaffected, moderately affected, and severely af-
fected) by use of score statistics for the proportional odds
model, a multivariate GLM (details are available on
request).
Score Statistics
With the above results, we can compute a global score
statistic according to
′ 1Sp U V U . (3)b b b
This score statistic has a large sample x2 distribution
with degrees of freedom equal to the rank of , althoughVb
the generalized inverse of may be required when it isVb
not of full rank. This score statistic is asymptotically
equivalent to the likelihood-ratio test statistic but avoids
the need to compute maximum-likelihood estimates of
b. Although maximum-likelihood estimates of the hap-
lotype probabilities under the null hypothesis are re-
quired, to compute subject-specific posterior probabili-
ties, the score statistic is not penalized for having
estimated the haplotype probabilities, because the score
vector for b and the score vector for the haplotype prob-
abilities are independent under the null hypothesis (see
Appendix A).
An advantage of our approach is that in addition to
a global statistic, we can readily compute score statistics
for the components of the vectors, such as individualXg
haplotypes, according to the following expression for
the kth component, , which has a stan-z p U / Vk b,k b,k,k
dard normal distribution for large samples (although we
use a distribution for to compute a two-sided P2 2x z1 k
value). Furthermore, if the effect of a single haplotype
is much larger than that for all other haplotypes, then
the maximum value of , maximized over all evaluated2zk
haplotypes indexed by k, is likely to have greater power
than the quadratic statistic of equation (3). However,
when several haplotypes are associated with the trait,
perhaps because of incomplete LD, which may be the
more common situation, the quadratic equation (3) may
be the better alternative. Although the distribution of
max( ) is not well defined and although P values could2zk
be approximated by the Bonferonni correction, it may
be more reliable to compute the empirical P value by
simulations, as discussed in the next subsection.
Empirical P Values
When the haplotype data is sparse, we may need to
compute empirical P values by simulations. A substantial
advantage of the use of score statistics, over likelihood-
ratio tests that require maximization of the likelihood, is
the ability to rapidly compute the score statistics. Empir-
ical P values can be computed by repeatedly first per-
muting the marker phenotypes among the subjects and
then computing the score statistics. Under the null hy-
pothesis that none of the haplotypes are associated with
the trait, it is appropriate to pool all subjects and then
use the EM algorithm to compute the haplotype proba-
bilities and the posterior genotype probabilities for each
subject. These posterior probabilities need to be computed
only once, because they are not altered by permutation
of the marker phenotypes. It is computationally efficient
to compute the values of for each subject only onceE ()p
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and to store them for reuse. However, the storage issues
are not as simple for , because one would need to storeVb
the matrix for each subject, which could con-′E (X X )p g g
sume significant computer memory. Instead, we store the
values of for each subject, along with their posteriorXg
probabilities, to rapidly compute for each per-′E (X X )p g g
mutation of the marker phenotypes.
Haplotype and Genotype Scoring
The multilocus genotypes, composed of two haplotypes,
can be scored a number of ways. A simple scheme is to
count the number of haplotypes that a subject possesses.
This is accomplished by creation of a vector X with a
value of 0, 1, or 2 for the count of haplotypes, which
has length , where H is the number of distinguish-H 1
able haplotypes (one haplotype is ignored, analogous to
treating it as a baseline in regression). When there are
a large number of haplotypes, this global score statistic
will be weakly powered. One way to avoid diminished
power, as well as to improve the approximation of the
score statistic by the x2 distribution, is to pool rare hap-
lotypes into a single baseline group.
Another approach is to scan a large chromosomal
region for subsegments that may be associated with the
trait. Begin with single-locus associations, followed by
“sliding” scores for two-locus haplotypes (i.e., sliding
a score for haplotypes defined by adjacent pairs of loci
across the entire measured chromosomal region), fol-
lowed by sliding scores for three-locus haplotypes, and
so forth (Clayton and Jones 1999). Alternatively, when
particular haplotypes are found to be associated with
the trait, it may be of interest to determine whether the
alleles of a haplotype have a stronger effect in cis po-
sition than in trans position. For example, suppose that
there are two loci, with alleles A and a at the first locus
and B and b at the second locus. To evaluate whether
the genotype AB/ab has a stronger effect on the trait
than the genotype Ab/aB has, we could create a covari-
ate that has values of 1, for genotype AB/ab; of 1, for
genotype Ab/aB; and of 0, for all other genotypes.
The above examples provide some guidelines on how
one could consider scoring multilocus genotypes.More-
complicated scoring schemes, such as ways to score for
particular interactions among alleles, could be devel-
oped. An advantage of our general approach is that,
once a scoring scheme is defined and appropriate X co-
variates are created, computation of the score statistics,
as well as of the empirical P values, is straightforward.
EM Algorithm for Haplotypes
Although the EM algorithm, which is used to estimate
haplotype frequencies for unrelated subjects, has been
implemented in a number of software packages (Ter-
williger and Ott 1994; Excoffier and Slatkin 1995; Haw-
ley and Kidd 1995; Long et al. 1995; Slatkin and Ex-
coffier 1996; Schneider et al. 2000), we briefly review
some of the key features of our algorithm that decrease
computation time. The input data are arranged as a ma-
trix, with N rows representing N subjects and 2K col-
umns representing pairs of alleles for K loci whose phase
is unknown. Two aspects achieve the speed of our al-
gorithm: (1) the use of functions to quickly index multi-
locus-marker phenotypes (as well as similar methods for
haplotypes); and (2) the storage, in memory, of inter-
mediate results to avoid recomputations. The input-data
matrix can be reduced to sufficient statistics, which are
the counts of the distinguishable configurations of multi-
locus-marker phenotypes. These counts are stored, and,
then, for each distinguishable configuration, all possible
pairs of haplotypes are enumerated. Each enumerated
haplotype is given an integer value that represents its
grouping according to the unique haplotypes, which is
then used as an index to rapidly determine its corre-
sponding probability during the iterations of the EM
algorithm.
Availability of Software
The software that implements the computation of score
statistics for the association of ambiguous haplotypes
with a variety of traits was developed in the program-
ming language S-PLUS (Insightful). Our software is
available from our Web site (Statistical and Genetic Ep-
idemiology, Health Sciences Research–Mayo Clinic), al-
though interested users must also have S-PLUS on their
computer system.
Application of Score Statistics
Because failure of measles vaccination to stimulate an-
tibody formation is a major individual and public health
risk, a study was conducted at the Mayo Clinic to de-
termine the association between HLA alleles and im-
mune response following measles vaccination. The HLA
genes produce proteins that bind with antigenic peptides
and display them to T cells, which ultimately stimulate
an immune response. For this reason, the HLA genes
are ideal candidates to evaluate for their associationwith
serologic response to vaccination. A total of 220 unre-
lated subjects were evaluated for their antibody levels,
measured by the enzyme-linked immunosorbent assay
test and described elsewhere (Poland et al. 2002). The
study was approved by the Mayo Clinic institutional
review board, and informed consent was obtained from
participants. The level of antibody response is a quan-
titative measurement, although values !0.8 are consid-
ered to be a clinically negative response. Hence, we can
evaluate the association between HLA alleles and either
a binary trait (having values of 1, if negative response,
and of 0, if positive response) or a quantitative trait.
Eleven HLA loci were measured, and the association of
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Table 2
Haplotypes Most Strongly Associated with Antibody Response to Measles Vaccination
HAPLOTYPE
FREQUENCY
BINARY TRAIT QUANTITATIVE TRAIT
HAPLOTYPE
Score
P Value
Score
P Value
DQB DRB HLA-B
2x1 Simulation
2x1 Simulation
63 13 60 .006 2.144 .032 .033 1.651 .099 .096
31 4 44 .029 2.534 .011 .014 2.267 .023 .020
21 7 13 .011 3.693 .000 .001 2.315 .020 .022
21 3 8 .105 3.823 .000 .000 2.450 .014 .012
each locus with both the binary and quantitative traits
were evaluated by use of our score tests. On the basis
of individual locus evaluations, three loci—DQB, DRB,
and HLA-B—demonstrated statistically significant as-
sociations with binary response; the number of alleles
at each of these loci in our sample were 12, 11, and 24,
respectively, thereby demonstrating the highly polymor-
phic information for which the HLA region is well
known. Both binary and quantitative traits were then
evaluated for their associations with haplotypes com-
posed of these three loci. Among the 220 subjects, there
were a total of 678 enumerated haplotypes that were
consistent with the observed alleles at the three loci.
However, only 178 haplotypes had nonzero probability
estimates. After we pooled the rare haplotypes (with es-
timated frequencies !0.005) into a single group, there
remained 40 haplotypes to evaluate. For the binary trait,
the global score statistic was 65.874, and, with 40 df,
the P value from the distribution was .006; this P2x
value was identical to the empirical P value based on
1,000 simulation repetitions. The empirical P value for
the max( ) statistic was .004. For the quantitative trait,2zk
the results were not as striking. The global score statistic
was 46.605, with a P value of .219, which is in close2x
agreement with the empirical P value of .224. The em-
pirical P value for the max( ) statistic was .318.2zk
The haplotypes most strongly associated with both
binary and quantitative traits, as judged by the haplo-
type-specific scores, are given in table 2. In terms of
relative significance, the haplotype-specific scores were
consistent between the binary and quantitative traits,
both of which yielded the same extreme haplotypes. The
scores for the quantitative trait are negative, because the
four extreme haplotypes are associated with a lower-
than-average response, and the scores for the binary trait
are positive, because if the response is lower thanyp 1
a minimum cutoff. An advantage of our method is dem-
onstrated by the haplotype-specific scores, which allow
the evaluation of which haplotypes have the strongest
association with a trait. For the results given in table 2,
the P values between the asymptotic distribution and2x1
simulations are very similar. A comparison of all 40 hap-
lotype-specific P values for both binary and quantitative
traits is provided in figure 1. For the quantitative trait,
which is assumed to have a normal distribution, the
and empirical P values were remarkably close. How-2x1
ever, for the binary trait, the empirical P values tended
to be greater than the P values, suggesting that the2x1
approximation may not be adequate. Although the2x1
purpose of our analyses is to illustrate the utility of our
new methods, as well as the adequacy of the distri-2x
bution relative to simulation P values, we should note
that first exploring individual locus associations, as we
had done to select the three most interesting loci, and
then evaluating haplotypes on the basis of the most sig-
nificant ones can bias the haplotype P values. This ap-
proach does not invalidate our comparisons of asymp-
totic versus simulation P values, conditional on which
loci were selected, but it is an approach that requires
caution when attempting to build significant haplotypes
from prior significance testing. To further evaluate the
adequacy of the distribution, simulations were per-2x
formed, as discussed in the next section.
Simulation Methods to Evaluate Type I Error Rates
To evaluate the type I error rates of the approxi-2x
mations for both the global statistic and the haplotype-
specific statistics, simulations were performed by using
our observed marker phenotypes for the three HLA loci
and randomly assigning traits to the 220 subjects. For
binary traits, the percentage of diseased subjects was
simulated at 20% and 50% (e.g., 50% typical in case-
control studies). Quantitative traits were simulated by
three different distributions: (1) a standard normal dis-
tribution; (2) an exponential distribution, to evaluate the
influence of skewed traits (both the simulated trait and
a log transformation of the trait were analyzed); and (3)
a t distribution with 5 df, to evaluate the influence of
kurtosis (this t distribution has a kurtosis of 9, which is
much greater than the kurtosis of 3 for a standard nor-
mal distribution, and, hence, has much heavier tails than
a normal distribution).
Simulation Results
The type I error rates for the score statistics with a binary
trait are presented in table 3. When the fraction of dis-
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Figure 1 Comparison of P values for haplotype-specific score statistics. P values were computed by the distribution (i.e., ) versus2 2x x1
simulations, to test the association of HLA haplotypes with failure to demonstrate an immune response (binary trait [A]) or with a quantitative
antibody level (quantitative trait [B]).
Table 3
Type I Error Rates for Global and Haplotype-Specific Score Statistics for a Binary
Trait
FREQUENCY OF SKIPPED
HAPLOTYPESa (NO. EVALUATED),
FOR PERCENTAGE DISEASED
NOMINAL
TYPE I
ERROR
RATE
SIMULATION P VALUES FOR
Global
Score
Statistic
Haplotype-Specific
Score Statisticsb
Median Mean
50:
!.005 (n p 40) .05 .027 .036 .032
.01 .002 .000 .003
!.01 (n p 21) .05 .025 .049 .048
.01 .002 .006 .005
20:
!.005 (n p 40) .05 .120 .049 .051
.01 .073 .014 .015
!.01 (n p 21) .05 .070 .043 .043
.01 .022 .014 .014
a “Skipped haplotypes” are not evaluated but are pooled into a single baseline group
when their frequencies are less than the threshold in column 2.
b Median and mean P values are over the number of evaluated haplotype-specific
scores.
eased subjects was 50%, which is typical for case-control
study designs, the global score statistic tended to be
somewhat conservative. In contrast, the global score sta-
tistic tended to be anticonservative when the fraction of
diseased subjects was only 20% and, particularly, when
a large number of rare haplotypes were evaluated. This
suggests that the approximation is inadequate for2x
such sparse data and that P values based on simulations
would be preferred. However, when considering the av-
erage P values for the haplotype-specific score statistics,
averaged over all evaluated haplotypes, it appears that
the distribution with 1 df yields a good approxima-2x
tion for the haplotype-specific score statistics.
The type I error rates for quantitative traits are pre-
sented in table 4. When the trait had a normal distri-
bution, the approximation for the global statistic, as2x
well as that for the haplotype-specific statistics, ap-
peared to be adequate. When the trait was skewed (i.e.,
had an exponential distribution) or when the trait dis-
tribution had heavy tails (i.e., was the t distribution),
the P values for the global statistics were somewhat2x
anticonservative, although this problem was diminished
by eliminating the rare haplotypes and, for the skewed
trait, by taking the log transformation of the trait. It is
of interest that the distribution with 1 df yields a2x
good approximation for the haplotype-specific score
statistics, thereby suggesting that the haplotype-specific
score statistics tend to be fairly robust to departures
from a normal distribution.
Discussion
Our proposed methods, which are based on score equa-
tions for GLMs, provide several significant advantages
over other current methods of analysis for associations
of ambiguous haplotypes with traits. The most obvious
advantage is that a wide variety of traits can be evalu-
ated, in contrast to the likelihood-ratio statistic that is
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Table 4
Type I Error Rates for Global and Haplotype-Specific Score Statistics for
Quantitative Traits
FREQUENCY OF SKIPPED
HAPLOTYPESa (NO. EVALUATED),
FOR TRAIT DISTRIBUTION
NOMINAL
TYPE I
ERROR
RATE
SIMULATION P VALUES FOR
Global
Score
Statistic
Haplotype-Specific
Score Statisticsb
Median Mean
Normal:
!.005 (n p 40) .05 .063 .051 .052
.01 .022 .011 .011
!.01 (n p 21) .05 .048 .052 .053
.01 .014 .011 .011
Exponential:
!.005 (n p 40) .05 .084 .047 .047
.01 .037 .018 .019
!.01 (n p 21) .05 .078 .047 .048
.01 .024 .017 .017
Exponential, log transformed:
!.005 (n p 40) .05 .069 .051 .051
.01 .023 .013 .015
!.01 (n p 21) .05 .060 .050 .050
.01 .018 .012 .012
t Distribution (5 df):
!.005 (n p 40) .05 .077 .047 .047
.01 .032 .019 .019
!.01 (n p 21) .05 .064 .043 .044
.01 .028 .015 .016
a “Skipped haplotypes” are not evaluated but are pooled into a single baseline group
when their frequencies are less than the threshold in column 1.
b Median and mean P values are over the number of evaluated haplotype-specific
scores.
widely used to compare haplotype frequencies between
cases and controls. We have currently developed score
statistics that can be used for binary, Poisson-count, or-
dinal, and quantitative traits. Further developments are
planned for other types of study designs and traits, such
as matched case-control designs and censored survival
data. Other advantages of our general approach are (1)
that haplotype-specific scores can be easily computed,
allowing evaluation of individual haplotypes when the
global score statistic indicates statistical significance; (2)
that, in addition to the global quadratic statistic, the
max( ) statistic, as well as its simulation P value, can2zk
be easily computed to evaluate whether only a few hap-
lotypes are strongly associated with a trait; (3) that sim-
ulation P values can be computed in an efficient manner;
and (4) that adjustment for nongenetic covariates can
be readily implemented.
Although simulation P values may be most reliable
when the data is sparse, the computational burden to
compute them increases as the number of loci in the
haplotypes increases. Our simulations suggest that the
P values approximated by the distribution for the2x
global score statistic are adequate when a case-control
study is balanced between cases and controls or when
a trait is not highly skewed and when rare haplotypes
are eliminated. It may be reasonable to screen for hap-
lotype associations by use of the approximation and2x
then to confirm suggestive findings with simulation P
values. To provide some guidance on the computational
efficiency of the score statistic versus the likelihood-
based method (for case-control data), we computed the
relative central-processing-unit time for 100 simula-
tions. For our example data, which included 220 sub-
jects and three loci, 19 subjects had one possible hap-
lotype pair (i.e., no ambiguity), 55 subjects had two
possible haplotype pairs, and 146 subjects had four pos-
sible haplotype pairs. The likelihood method took 13.4
times longer (in the central processing unit) than the
score statistic. However, efficiency depends on the
amount of haplotype ambiguity and, hence, on the num-
ber of loci in the haplotype. To illustrate this, we simply
repeated our three loci, to create six loci per subject.
With a greater amount of haplotype ambiguity (i.e., 4
subjects with 1 possible haplotype pair; 15 subjects with
2 possible haplotype pairs; 66 subjects with 8 possible
haplotype pairs; and 146 subjects with 32 possible hap-
lotype pairs), the likelihood method took 25.0 times
longer than the score statistic, so the benefit of the score
statistics increases as the haplotype ambiguity becomes
greater.
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Some limitations of the likelihood approach to the
estimation of haplotype frequencies are that it requires
large amounts of computer memory and processing
time, both of which grow exponentially with the num-
ber of heterozygous loci, and that the final solution can
depend on the initial starting values used for the hap-
lotype frequencies, so that it may be necessary to use
several different starting values to find the solution that
yields the maximum likelihood. Some recent studies on
the utility of the likelihood method (Fallin and Schork
2000; Tishkoff et al. 2000; Fallin et al. 2001) have re-
ported the following properties: (1) it provides accurate
estimates of the most frequent haplotypes but tends to
be inaccurate for rare haplotypes (Tishkoff et al. 2000);
(2) the inaccuracies for small frequencies can be caused
by their large sampling variation (Fallin and Schork
2000), as well as by the allele frequencies and amount
of LD (McKeigue 2000); and (3) the accuracy of the
method increases as the LD among the marker loci in-
creases (Fallin and Schork 2000). Finally, when the as-
sumption of Hardy-Weinberg proportions for genotypes
is violated with an excess of heterozygotes, the error of
the EM procedure is increased, although the error is not
increased with an excess of homozygotes (Fallin and
Schork 2000). Further simulations are required to eval-
uate how robust our score statistics are to departures
from the Hardy-Weinberg assumption, as well as to
evaluate the power of our methods. We are also devel-
oping methods that account for departures fromHardy-
Weinberg genotype proportions and plan to evaluate
whether they provide a robust method when incorpo-
rated into our haplotype-scoring algorithms.
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Appendix A
A brief outline of why the score vector for b and the
score vector for the haplotype probabilities are inde-
pendent under the null hypothesis is provided, although
many of the detailed intermediate steps are skipped for
the sake of brevity. If h denotes the vector of haplotype
probabilities, which determine the genotype probabili-
ties, then we wish to show that .2E ( lnL/bh)p 0
To see this, note that
2
˜ lnL (y y)
 p  Cov (X ,W) ,g gpbh a(f)
whereWgp , P[gp (i/j)]p [2I(ip j)]hihj, lnP (g) /h
i and j are particular haplotypes, and is theCov (X,W)p
covariance of X and W over the posterior distribution
of genotypes. The expected value of this expression is
zero, because .˜E (y y)p 0
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